Clinical Trial Update: Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating varlitinib plus capecitabine in Chinese patients with advanced or metastatic biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Varlitinib (varlitinib)

Snippet

Sponsor: ASLAN Pharmaceuticals | Conditions: Biliary Tract Cancer | Phase 2 | Status: COMPLETED